ESC 365 - Long-term outcomes after catheter ablation of ventricular tachycardia in patients with structural heart disease: a Multicentre UK Study

EHRA Premium Access

Long-term outcomes after catheter ablation of ventricular tachycardia in patients with structural heart disease: a Multicentre UK Study

Session: Moderated Poster session 5 - Treatment strategies and ablation outcome

Topic: Ventricular tachycardia ablation

Speaker: Doctor A. Breitenstein (Zurich, CH)

Event: EHRA EUROPACE - CARDIOSTIM 2017

Congress Presentation

Add to my library

About the speaker

Doctor Alexander Breitenstein

University Heart Center, Zurich (Switzerland)

14 presentations

0 follower

7 more presentations in this session

Efficacy of non-vitamin k antagonist oral anticoagulants for perioperative complication in patients with atrial fibrillation undergoing catheter ablation.

Speaker: Doctor T. Iseda (Wakayama, JP)

Predictors of serious complications during and immediately after catheter ablation of atrial fibrillation in 8302 procedures: J-CARAF Study

Speaker: Professor Y. Murakawa (Kawasaki, JP)

Is the transesophageal echocardiography mandatory in patients undergoing atrial fibrillation ablation with uninterrupted novel anticoagulants?

Speaker: Doctor A. Shapieva (Moscow, RU)

The incidence of complications in the setting of second-generation cryoballoon ablation of atrial fibrillation: a comparison between vitamin K antagonists and novel oral anticoagulants

Long-term outcomes of supraventricular tachycardia ablation in congenital heart disease: single centre uk experience

Speaker: Doctor V. Sawhney (London, GB)

Access the full session

Moderated Poster session 5 - Treatment strategies and ablation outcome

Speakers: Doctor A. Breitenstein, Doctor T. Iseda, Professor Y. Murakawa, Doctor A. Shapieva, Doctor V. Sawhney

About the event

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources